Open Access Research article

A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NF-kappaB activity in human liver cancer cell lines

Christian Freise1, Martin Ruehl1, Ulrike Erben1, Ulf Neumann23, Daniel Seehofer2, Ki Young Kim4, Wolfram Trowitzsch-Kienast5, Thorsten Stroh1, Martin Zeitz1 and Rajan Somasundaram1*

Author affiliations

1 Department of Gastroenterology, Infectiology and Rheumatology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany

2 Department of General, Visceral and Transplantation Surgery, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353Berlin, Germany

3 Department of Surgery, University Hospital Aachen, Pauwelstraße 30, 52074 Aachen, Germany

4 Faculty of Beauty Design, Human Environmental Science College, Wonkwang University, Iksan City, South Korea

5 Department of Chemical and Pharmaceutical Engineering, Beuth Hochschule für Technik, Luxemburger Str. 10, 13353 Berlin, Germany

For all author emails, please log on.

Citation and License

BMC Complementary and Alternative Medicine 2011, 11:39  doi:10.1186/1472-6882-11-39

Published: 12 May 2011

Abstract

Background

In traditional Chinese and Korean medicine, an aqueous extract derived from wood and bark of the Japanese spice bush Lindera obtusiloba (L.obtusiloba) is applied to treat inflammations and chronic liver diseases including hepatocellular carcinoma. We previously demonstrated anti-fibrotic effects of L.obtusiloba extract in hepatic stellate cells. Thus, we here consequently examine anti-neoplastic effects of L.obtusiloba extract on human hepatocellular carcinoma (HCC) cell lines and the signaling pathways involved.

Methods

Four human HCC cell lines representing diverse stages of differentiation were treated with L.obtusiloba extract, standardized according to its known suppressive effects on proliferation and TGF-β-expression. Beside measurement of proliferation, invasion and apoptosis, effects on signal transduction and NF-κB-activity were determined.

Results

L.obtusiloba extract inhibited proliferation and induced apoptosis in all HCC cell lines and provoked a reduced basal and IGF-1-induced activation of the IGF-1R signaling cascade and a reduced transcriptional NF-κB-activity, particularly in the poorly differentiated SK-Hep1 cells. Pointing to anti-angiogenic effects, L.obtusiloba extract attenuated the basal and IGF-1-induced expression of hypoxia inducible factor-1α, vascular endothelial growth factor, peroxisome proliferator-activated receptor-γ, cyclooxygenase-2 and inducible nitric oxide synthase.

Conclusions

The traditional application of the extract is confirmed by our experimental data. Due to its potential to inhibit critical receptor tyrosine kinases involved in HCC progression via the IGF-1 signaling pathway and NF-κB, the standardized L.obtusiloba extract should be further analysed for its active compounds and explored as (complementary) treatment option for HCC.